Logo + Home
 
   BQS Online    BQS Outcome    BQS Qualitätsindikatoren Datenbank

Literatur

AHRQ (Nationwide Inpatient sample).
Healthcare Cost and Utilisation Project. Agency for Healthcare Research and Quality, Rockville MD.
http://www.hcup.ahrq.gov/HCUPnet.asp (Recherchedatum: 23.03.2005).

Bederman SS, Betsy M, Winiarsky R, Seldes RM, Sharrock NE, Sculco TP.
Postoperative ileus in the lower extremity arthroplasty patient.
J Arthroplasty 2001; 16 (8): 1066-1070.

Choi PT, Bhandari M, Scott J, Douketis J.
Epidural analgesia for pain relief following hip or knee replacement. (Cochrane Review 2003).
In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.

Colwell CW, Jr., Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
J Bone Joint Surg Am 1994; 76 (1): 3-14.

Dunsmuir RA, Allan DB, Davidson LA.
Early post-operative mortality following primary total hip replacement.
J R Coll Surg Edinb 1996; 41 (3): 185-187.

Duppils GS, Wikblad K.
Acute confusional states in patients undergoing hip surgery. A prospective observation study.
Gerontology 2000; 46 (1): 36-43.

Eikelboom JW, Quinlan DJ, Douketis JD.
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
Lancet 2001; 358 (9275): 9-15.

Freedman KB, Brookenthal KR, Fitzgerald RH, jr, Williams S, Lonner JH.
A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty.
The Journal of Bone and Joint Surgery 2000; 82-A (7): 929-938.

Gillespie W, Murray D, Gregg PJ, Warwick D.
Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery.
The Journal of Bone and joint surgery 2000; 82-B (4): 475-479.

Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.
Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty – A Systematic Review.
Archieves of Internal Medicine 2001; 161 (16): 1952-1960.

Kassim RA, Saleh KJ, Almacari G, Badra M, Young K, Esterberg JL.
Systemic complications following total hip arthroplasty.
J South Orthop Assoc 2003; 12 (2): 112-116.

Khuri SF, Daley J, Henderson W, Hur K, Hossain M, Soybel D, Kizer K, Aust JB, Bell RH, jr, Chong V, Demakis J, Fabri PJ, Gibbs JO, Grover F, Hammermeister K, McDonald G, Passaro E, jr, Phillips L, Scamman F, Spencer J, Stremple JF.
VA National Surgical Quality Improvement Program. Relation of surgical volume to outcome in eight common operations.
Annals of Surgery 1999; 230 (3): 414-432.

Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA.
Rates and Outcomes of Primary and Revision Total Hip Replacement in the United States Medicare Population.
The Journal of Bone and Joint Surgery 2003; 85-A (1): 27-32.

Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.
Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.
Anesthesiology 2002; 96 (5): 1140-1146.

Merx H, Dreinhöfer K, Schräder P, Stürmer T, Puhl W, Günther K-P, Brenner H.
International variation in hip replacement rates.
Ann Rheum Dis 2003; 62: 222-226.

O'Donnell M, Linkins LA, Kearon C, Julian J, Hirsh J.
Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review.
Arch Intern Med 2003; 163 (11): 1362-1366.

Pitto RP, Koessler M, Kuehle JW.
Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty. A prospective, randomized clinical trial.
J Bone Joint Surg Am 1999; 81 (6): 831-843.

Reginster J-Y, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C.
Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS Trial.
Osteoporosis International 2002; 13: 925-931.

Statistisches Bundesamt.
http://www.destatis.de/basis/d/gesu/gesutab11.php (Recherchedatum 06.06.2005 .

Strebel N, Prins M, Agnelli G, Buller HR.
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
Arch Intern Med 2002; 162 (13): 1451-1456.

Thompson R, Kane RL, Gromala T, McLaughlin B, Flood S, Morris N, Borbas C.
Complications and short-term outcomes associated with total hip arthroplasty in teaching and community hospitals.
The Journal of Arthroplasty 2002; 17 (1): 32-40.

Tryba M, Linde I, Voshage G, Zenz M.
Histamine release and cardiovascular reactions to implantation of bone cement during total hip replacement.
Anaesthesist 1991; 40 (1): 25-32.

Wurtz LD, Feinberg JR, Capello WN, Meldrum R, Kay PJ.
Elective primary total hip arthroplasty in octogenarians.
J Gerontol A Biol Sci Med Sci 2003; 58 (5): M468-M471.